Figueroa-Sánchez M, Núñez-Atahualpa L, Hernández-Zúñiga M, Martín-Marquez BT, Martínez-García EA, Gómez-Bañuelos E, Navarro-Hernández RE, Vázquez-Del Mercado M

Language: Spanish
References: 29
Page: 432-437
PDF size: 185.64 Kb.

ABSTRACT

Introduction: Patients with rheumatoid arthritis can develop autoimmune thyroid disease (ATD), the clinical diagnosis of which can be difficult because both entities share symptoms such as arthralgia, myalgia, morning stiffness or fatigue. Objective: To determine the prevalence of ATD in patients with rheumatoid arthritis. Method: Cross-sectional study that included 78 patients with rheumatoid arthritis and 81 clinically healthy controls matched by age and gender. Both groups underwent anti-thyroid antibodies quantification, thyroid function tests, thyroid ultrasound and thyroid gland biopsy when the Thyroid Imaging Reporting and Data System (TIRADS) score was ≥ 4. Results: Hypothyroidism was found in 24.4% of patients with rheumatoid arthritis (p = 0.003), as well as high titers of anti-thyroid antibodies versus clinically healthy controls; 53% of thyroid ultrasounds were normal in hypothyroid patients, and increased perfusion was found in 40% of rheumatoid arthritis patients who tested positive for anti-thyroid antibodies. Cases classified as TIRADS 4 underwent aspiration with benign histopathological results. Conclusions: Thyroid assessment added clinical value was demonstrated in patients with rheumatoid arthritis, according to the prevalence of subclinical hypothyroidism, anti-thyroid antibodies positivity and ultrasound abnormalities, regardless of normal or altered thyroid function.

REFERENCES

1. Vázquez-Del Mercado M, Nuñez-Atahualpa L, Figueroa-Sánchez M, Gómez- Bañuelos E, Rocha-Muñoz AD, Martín-Márquez BT, et al. Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-alpha, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors. Biomed Res Int. 2015;2015:342649.

2. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-2219.

3. Dong YH, Fu DG. Autoimmune thyroid disease: mechanism, genetics and current knowledge. Eur Rev Med Pharmacol Sci. 2014;18(23): 3611-3618.

4. Cárdenas Roldán J, Amaya-Amaya J, Castellanos-De-La-Hoz J, Giraldo- Villamil J, Montoya-Ortiz G, Cruz-Tapias P, et al. Autoimmune thyroid disease in rheumatoid arthritis: a global perspective. Arthritis. 2012;2012:864907.

5. Robazzi TC, Adan LF. Autoimmune thyroid disease in patients with rheumatic diseases. Rev Bras Reumatol. 2012;52(3):417-430.

6. Shiroky JB, Cohen M, Ballachey ML, Neville C. Thyroid dysfunction in rheumatoid arthritis: a controlled prospective survey. Ann Rheum Dis. 1993;52(6):454-456.

7. Atzeni F, Doria A, Ghirardello A, Turiel M, Batticciotto A, Carrabba M, et al. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value. Autoimmunity. 2008;41(1):111-115.

8. Przygodzka M, Filipowicz-Sosnowska A. Prevalence of thyroid diseases and antithyroid antibodies in women with rheumatoid arthritis. Pol Arch Med Wewn. 2009;119(1-2):39-43.

9. Yavasoglu I, Senturk T, Coskun A, Bolaman Z. Rheumatoid arthritis and anti-thyroid antibodies. Autoimmunity. 2009;42(2):168-169.

10. Andonopoulos AP, Siambi V, Makri M, Christofidou M, Markou C, Vagenakis AG. Thyroid function and immune profile in rheumatoid arthritis. A controlled study. Clin Rheumatol. 1996;15(6):599-603.

11. Mobini M, Kashi Z, Ravanbakhsh N. Thyroid disorders in rheumatoid arthritis and osteoarthritis. Pak J Med Sci. 2011;27(3) 595-598.

12. Del Puente A, Savastano S, Nuzzo V, Esposito A, Lupoli G. High prevalence of thyroid autoantibodies in newly diagnosed rheumatoid arthritis patients. Clin Exp Rheumatol. 2003;21(1):137.

13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-324.

14. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism Collaborative Initiative. Arthritis Rheum Dis. 2010;69(9):2569-2581.

15. Prevoo ML, Van-’t-Hof MA, Kuper HH, Van-Leeuwen MA, Van- De-Putte LB, Van-Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44-48.

16. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):123-126.

17. Horvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab. 2009;94(5):1748-1751.

18. Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011; 260(3):892-899.

19. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159-1165.

20. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Prac. 2010;16(3): 468-475.

21. Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009;84(1):65-71.

22. Peeters RP. Subclinical Hypothyroidism. N Engl J Med. 2017;377(14):1404.

23. Mincer DL, Jialal I. Thyroid, Hashimoto thyroiditis. Treasure Island (FL): StatPearls Publishing; 2018.

24. Iddah MA, Macharia BN. Autoimmune thyroid disorders. ISRN Endocrinol. 2013;2013:509764.

25. Engler H, Riesen WF, Keller B. Diagnostic value of autoantibodies against microsomal thyroid peroxidase (anti-TPO). Schweiz Med Wochenschr. 1992;122(51-52):1976-1980.

26. Buchanan WW. The relationship of Hashimoto’s thyroiditis to rheumatoid arthritis. Geriatrics. 1965;20(11):941-948.

27. Hartmann K. Thyroid disorders in the oncology patient. J Adv Pract Oncol. 2015;6(2):99-106.

28. Li H, Li J. Thyroid disorders in women. Minerva Med. 2015;106(2):109-114.

29. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-1214.